5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 393-399

  Coffey, Michael J ^a,b   Phare, Susan M ^a   Kazanjian, Powel H ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID DERIVATIVE; LEUKOTRIENE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LYMPHOCYTE COUNT; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; CULTURE MEDIA, CONDITIONED; ENZYME ACTIVATION; FEMALE; HIV INFECTIONS; HUMANS; LEUKOTRIENE B4; MACROPHAGES, ALVEOLAR; MALE; MEMBRANE PROTEINS; MIDDLE AGED; TRITIUM;

EID: 0030013194     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Murray, J. F., C. P. Felton, S. M. Garay, M. S. Gottlieb, P. C. Hopewell, D. E. Stover, and A. S. Teirstein. 1984. Pulmonary complications of the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:1682.
2. Centers for Disease Control, U. S. Department of Health and Human Services. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann. Int. Med. 105:234.
3. Falco, V., T. Fernandez, J. Alegre, J. Barbe, A. Ferrer, I. Ocana, E. Ribera, and J. Martinez-Vazquez. 1994. Bacterial pneumonia in HIV-infected patients: a prospective study of 68 episodes. Eur. J. Respir. Dis. 7:235.
4. Limper, A., K. Offord, T. Smith, and W. Martin II. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204.
5. Hirschtick, R., J. Glassroth, M. Jordan, T. Wilcosky, J. Wallace, P. Kvale, N. Markowitz, M. Rosen, B. Mangura, P. Hopewell. 1995. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N. Engl. J. Med. 333:845.
6. Fels, A., and Z. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353.
7. + cells in the lung. Am. J. Respir. Cell. Mol. Biol. 1:391.
8. Foley, P., F. Kazazi, R. Biti, T. Sorrell, and A. Cunningham. 1992. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 75:391.
9. Twigg, H. 1993. Bronchoalveolar lavage fluid in HIV-infected patients: cytokine soup. Chest 104:659.
10. Lipschik, G., M. Doerfler, J. Kovacs, W. Travis, V. Andrawis, M. Lawrence, J. Dichter, F. Ognibene, and J. Shelhamer. 1993. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104: 763.
11. Mastino, A., S. Grelli, M. Piacentini, S. Oliverio, C. Favalli, C. Perno, and E. Garaci. 1993. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol. 152:120.
12. Needleman, P., J. Turk, B. A. Jakschik, A. R. Morrison, and J. B. Lefkowith. 1986. Arachidonic Acid Metabolism. Annu. Rev. Biochem. 55:69.
13. 4. J. Biol. Chem. 264:19469.
14. Dixon, R. A. F., R. E. Diehl, E. Opas, E. Rands, P. J. Vickers, J. F. Evans, J. W. Gillard, and D. K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282.
15. Mancini, J., M. Abramovitz, M. Cox, E. Wong, S. Charleson, H. Perrier, Z. Wang, P. Prasit, and P. Vickers. 1993. 5-Lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318:277.
16. Bigby, T., and M. Holtzman. 1987. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J. Immunol. 138: 1546.
17. Balter, M., G. Toews, and M. Peters-Golden. 1989. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages. J. Immunol. 142:602.
18. Peters-Golden, M., R. W. McNish. R. Hyzy, C. Shelly, and G. B. Toews. 1990. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J. Immunol. 144:263.
19. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568.
20. Lewis, R., K. Austen, and R. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human disease. N. Engl. J. Med. 323:645.
21. Miyamoto, K., G. McKinley, M. Lange, C. Stavropoulos, H. Matsumoto, S. Moriya, and Y. Inada. 1992. Effects of sho-saiko-to (SST) on production of prostaglandin E2 (PGE2), leukotriene B4 (LTB4) and superoxide from peripheral monocytes and neutrophils isolated from HIV infected individuals. Int. Conf. AIDS 8:A60.
22. Chang, K., H. Saito, I. Tatsuno, Y. Tamura, and S. Yoshida. 1991. Role of 5-lipoxygenase products of arachidonic acid in cell-to-cell interaction between macrophages and natural killer cells in rat spleen. J. Leukocyte Biol. 50:273.
23. Coffey, M., S. Wilcoxen, and M. Peters-Golden. 1994. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism which accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 11:153.
24. Coffey, M., M. Peters-Golden, J. Fantone, and P. Sporn. 1992. Membrane association of active 5-lipoxygenase in resting cells: evidence for novel regulation of the enzyme in the rat alveolar macrophage. J. Biol. Chem. 267:570.
25. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
26. Peters-Golden, M., and R, McNish. 1993. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:18.
27. Engels, W., P. Lemmens, A. Muller, M. Van Dam-Mieras, and G. Hornstra. 1992. The effect of viral infection on eicosanoid formation and procoagulant activity of rat peritoneal macrophages. Eicosanoids 5:73.
28. Castro, M., T. Morgenthaler, O. Hoffman, J. Standing, M. Rohrbach, and A. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 9:73.
29. Laviolette, M., R. Coulombe, S. Picard, P. Braquet, and P. Borgeat. 1986. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J. Clin. Invest. 77:54.
30. Balter, M., G. Toews, and M. Peters-Golden. 1989. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers. J. Lab. Clin. Med. 114:662.
31. Ho, D., T. Rota, and M. Hirsch. 1986. Infection of monocytes/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 77:1712.
32. Gartner, S., P. Markovits, M. Markovitz, M. Kaplan, R. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III LAV infection. Science 233:215.
33. Rose, R., A. Krivine, P. Pinkston, J. Gillis, A. Huang, and S. Hammer. 1991. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with acquired immunodeficiency syndrome. Am. Rev. Respir. Dis. 143:850.
34. Buhl, R., H. Jaffe, K. Holroyd, Z. Borok, J. Roum, A. Mastrangeli, F. Wells, M. Kirby, C. Saltini, and R. Crystal. 1993. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J. Immunol. 150:1019.
35. Rich, E., I. Chen, J. Zack, M. Leonard, and W. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:176.
36. Panuska, J., F. Midulla, C. NM, A. Villani, I. Gilbert, E. McFadden, Jr., and Y. Huang. 1990. Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. Am. J. Physiol. 259:L396.
37. Ananaba, G., and L. Anderson. 1991. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophage-like cell line. J. Virol. 65:5052.
38. Wahl, L., M. Corcoran, S. Pyle, L. Arthur, A. Harel-Bellan, and W. Farrar. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86:621.
39. Ring, W., C. Riddick, J. Baker, and T. Bigby. 1995. Activated lymphocytes upregulate expression of 5-lipoxygenase and its activating protein in monocytes via IL-3 or GM-CSF. Am. J. Respir. Crit. Care Med. 151:A677.
40. Curtis, J., and H. Kaltreider. 1989. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am. Rev. Respir. Dis. 139:393.
41. Saltini, C., M. Kirby, B. Trapnell, N. Tamura, and R. Crystal. 1990. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123.
42. Dominique, S., F. Bouchonnet, J. Smiejan, and A. Hance. 1990. Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluid. Thorax 43:391.
43. McColl, S., E. Krump, P. Naccache, P. Poubelle, M. Braquet, and P. Borgeat. 1991. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. J. Immunol. 146:1204.
44. Meslier, N., A. Aldrich, and T. Bigby. 1992. Effect of interferon-gamma on the 5-lipoxygenase pathway of rat lung macrophages. Am. J. Respir. Cell. Mol. Biol. 6:93.
45. Chen, X., J. Sheller, E. Johnson, and C. Funk. 1994. Role of leukotrienes revealed by targeting disruption of the 5-lipoxygenase gene. Nature 372:179.
46. Skerrett, S., W. Henderson, and T. Martin. 1990. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144:1052.
47. Bar-Shavit, Z., D. Noff, S. Edelstein, M. Meyer, S. Shibolet, and R. Goldman. 1981. 1,25-Dihydroxyvitamin D3 and the regulation of macrophage function. Calcif. Tissue Int. 33:673.
48. Lu, M.-C., D. Hostetler, N. Robinson, F. Derksen, and M. Peters-Golden. 1995. Age-related increases in 5-lipoxygenase activity of cattle alveolar macrophages. FASEB J. 9:3314.